- Home
- COLL vs HLIO Comparison
COLL vs HLIO Comparison
Compare COLL & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- HLIO
- Stock Information
- Founded
- COLL 2002
- HLIO 1970
- Country
- COLL United States
- HLIO United States
- Employees
- COLL N/A
- HLIO N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- HLIO Metal Fabrications
- Sector
- COLL Health Care
- HLIO Industrials
- Exchange
- COLL Nasdaq
- HLIO Nasdaq
- Market Cap
- COLL 958.8M
- HLIO 1.0B
- IPO Year
- COLL 2015
- HLIO N/A
- Fundamental
- Price
- COLL $32.38
- HLIO $35.63
- Analyst Decision
- COLL Strong Buy
- HLIO Strong Buy
- Analyst Count
- COLL 4
- HLIO 3
- Target Price
- COLL $43.75
- HLIO $42.67
- AVG Volume (30 Days)
- COLL 306.9K
- HLIO 511.2K
- Earning Date
- COLL 08-07-2025
- HLIO 08-04-2025
- Dividend Yield
- COLL N/A
- HLIO 1.02%
- EPS Growth
- COLL N/A
- HLIO 11.74
- EPS
- COLL 1.25
- HLIO 1.11
- Revenue
- COLL $664,283,000.00
- HLIO $789,400,000.00
- Revenue This Year
- COLL $20.04
- HLIO N/A
- Revenue Next Year
- COLL $3.98
- HLIO $4.69
- P/E Ratio
- COLL $25.16
- HLIO $31.88
- Revenue Growth
- COLL 17.17
- HLIO N/A
- 52 Week Low
- COLL $23.23
- HLIO $24.76
- 52 Week High
- COLL $42.29
- HLIO $57.29
- Technical
- Relative Strength Index (RSI)
- COLL 71.18
- HLIO 64.73
- Support Level
- COLL $30.60
- HLIO $35.24
- Resistance Level
- COLL $31.99
- HLIO $36.94
- Average True Range (ATR)
- COLL 0.80
- HLIO 1.22
- MACD
- COLL 0.17
- HLIO 0.26
- Stochastic Oscillator
- COLL 95.50
- HLIO 79.72
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.